看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -3.2x - -3.5x | -3.3x |
| Selected Fwd P/E Multiple | -5.8x - -6.4x | -6.1x |
| Fair Value | €2.86 - €3.17 | €3.02 |
| Upside | 6.9% - 18.1% | 12.5% |
| Benchmarks | - | Full Ticker |
| Abbott Laboratories | - | NYSE:ABT |
| Healthcare Triangle, Inc. | - | NasdaqCM:HCTI |
| JRSIS Health Care Corporation | - | OTCPK:JRSS |
| SCWorx Corp. | - | NasdaqCM:WORX |
| CareView Communications, Inc. | - | OTCPK:CRVW |
| SOPHiA GENETICS SA | - | BST:90B |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| ABT | HCTI | JRSS | WORX | CRVW | 90B | |||
| NYSE:ABT | NasdaqCM:HCTI | OTCPK:JRSS | NasdaqCM:WORX | OTCPK:CRVW | BST:90B | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 29.5% | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | 23.8% | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | 151.1% | 20.1% | -52.8% | 61.9% | -26.8% | -9.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 17.5% | -22.3% | 139.9% | -87.1% | -101.9% | -145.6% | ||
| Prior Fiscal Year | 14.2% | -26.2% | -33.5% | -104.6% | -40.8% | -126.6% | ||
| Latest Fiscal Year | 31.8% | -51.0% | -2.3% | -38.0% | -57.0% | -95.9% | ||
| Latest Twelve Months | 32.3% | -51.4% | -14.1% | -49.5% | -55.5% | -105.3% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 20.5x | -4.7x | -4.1x | NA | -23.7x | -2.7x | ||
| Price / LTM Sales | 5.3x | 1.6x | 0.4x | 0.4x | 1.3x | 3.0x | ||
| LTM P/E Ratio | 16.4x | -3.1x | -2.5x | -0.8x | -2.3x | -2.9x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -3.1x | -2.3x | 16.4x | |||||
| Historical LTM P/E Ratio | -14.3x | -3.7x | -1.4x | |||||
| Selected P/E Multiple | -3.2x | -3.3x | -3.5x | |||||
| (x) LTM Net Income | (73) | (73) | (73) | |||||
| (=) Equity Value | 233 | 245 | 257 | |||||
| (/) Shares Outstanding | 67.6 | 67.6 | 67.6 | |||||
| Implied Value Range | 3.44 | 3.62 | 3.81 | |||||
| FX Rate: USD/EUR | 1.2 | 1.2 | 1.2 | Market Price | ||||
| Implied Value Range (Trading Cur) | 2.95 | 3.10 | 3.26 | 2.68 | ||||
| Upside / (Downside) | 10.0% | 15.7% | 21.5% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | ABT | HCTI | JRSS | WORX | CRVW | 90B | |
| Value of Common Equity | 228,035 | 18 | 1 | 1 | 11 | 212 | |
| (/) Shares Outstanding | 1,740.5 | 5.8 | 84.6 | 3.6 | 583.9 | 67.6 | |
| Implied Stock Price | 131.02 | 3.04 | 0.01 | 0.32 | 0.02 | 3.13 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |
| Implied Stock Price (Trading Cur) | 131.02 | 3.04 | 0.01 | 0.32 | 0.02 | 2.68 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |